Mannkind (MNKD) Cash & Current Investments (2010 - 2026)

Mannkind's (MNKD) quarterly Cash & Current Investments came in at $134.6 million in Q1 2026, down 26.15% year-on-year from $182.3 million in Q1 2025, and down 21.78% on a QoQ basis from $172.1 million in Q4 2025.

Mannkind (MNKD) Cash & Current Investments (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Cash & Current Investments data on file, last reported at $134.6 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 26.15% year-over-year to $134.6 million in Q1 2026; TTM through Mar 2026 was $134.6 million, a 26.15% decrease from a year earlier, with the FY2025 full-year figure at $172.1 million, down 13.08% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $134.6 million, down from $172.1 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for MNKD reached as high as $300.7 million in Q1 2024 and fell as low as $134.6 million in Q1 2026.
  • Historically, Cash & Current Investments has averaged $195.8 million across 5 years, with a median of $172.1 million in 2025.
  • Across the five-year window, Cash & Current Investments slumped 41.33% in 2022 and jumped 81.01% in 2024, its largest moves.
  • Year by year, Cash & Current Investments stood at $170.8 million in 2022, then jumped by 72.73% to $295.1 million in 2023, then plunged by 32.91% to $198.0 million in 2024, then retreated by 13.08% to $172.1 million in 2025, then decreased by 21.78% to $134.6 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $134.6 million in Q1 2026, $172.1 million in Q4 2025, and $260.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 68,094.26 Bn 68,093.97 Bn - 283.54 Mn
2 Nanobiotix 1,939.09 Bn 1,939.02 Bn - 61.40 Mn
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - -
4 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 123.34 Bn 116.09 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.13 Bn 61.38 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.96 Bn 62.96 Bn - -
8 Argenx Se 56.38 Bn 51.20 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn 3.01 Bn
10 Mannkind 1.28 Bn 1.15 Bn 82.66 Mn 134.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 134.61 Mn
Dec 31, 2025 172.09 Mn
Sep 30, 2025 260.78 Mn
Jun 30, 2025 179.73 Mn
Mar 31, 2025 182.28 Mn
Dec 31, 2024 197.99 Mn
Sep 30, 2024 252.32 Mn
Jun 30, 2024 248.49 Mn
Mar 31, 2024 300.73 Mn
Dec 31, 2023 295.10 Mn
Sep 30, 2023 141.02 Mn
Jun 30, 2023 144.35 Mn
Mar 31, 2023 166.14 Mn
Dec 31, 2022 170.85 Mn
Sep 30, 2022 165.04 Mn
Jun 30, 2022 154.16 Mn
Mar 31, 2022 162.40 Mn
Dec 31, 2021 204.12 Mn
Sep 30, 2021 139.05 Mn
Jun 30, 2021 162.49 Mn